Transactions
Stephen Saad discusses the J&J vaccine release with eNCA’s Sally Burdett
Aspen confirmed on 26 July 2021 that the first supplies to South Africa of the Johnson & Johnson COVID-19 vaccines, from the new API source
Transactions
Aspen confirms release of Covid-19 vaccines to Johnson & Johnson for supply to South Africa
Durban, South Africa – Aspen, a global multinational specialty pharmaceutical company, is pleased to confirm that the first supplies to South Africa of the Johnson
Transactions
CNN Live – Aspen’s US$700m investment in equitable vaccine access for Africa
“Over 90% of our vaccines are imported. A high majority from #India. When India cut off all exports, #Africa was left without vaccines.” Stephen Saad,
Aspen statement on manufacture and supply of COVID-19 vaccines
Durban – Aspen, a global multinational specialty pharmaceutical company, was extremely disappointed to learn over the past weekend that specific batches of the Johnson &
Transactions
VIDEOS – Stephen Saad’s address on the occasion of President Cyril Ramaphosa’s visit at our Sterile Facility in the Eastern Cape
Stephen Saad’s address on the occasion of President Cyril Ramaphosa’s visit at our Sterile Facility in the Eastern Cape at which time he announced the agreement reached with Johnson & Johnson to supply 250 million covid-19 vaccines to Africa, with 30 million being for South Africa
Transactions
Aspen welcomes President Ramaphosa and his delegation to Aspen’s world class sterile manufacturing facility
Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today hosted President Cyril Ramaphosa and an accompanying government delegation at its flagship manufacturing site
Transactions
Stephen Saad, Aspen Chief Executive address to President Ramaphosa and his delegation at Aspen’s flagship manufacturing site in Gqberha, Eastern Cape
“Our Aspen philosophy has always been to give purpose to life. This is best achieved by contributing meaningfully to others. Aspen has defined itself and
Aspen concludes strategic partnership with US-based Avion Pharmaceuticals
Durban – United States-based Aspen Pharma USA Inc. and Aspen Global Incorporated, located in Mauritius, both wholly owned subsidiaries of Aspen Pharmacare Holdings Limited, have
Transactions
Aspen announces agreement with Johnson & Johnson to manufacture investigational COVID-19 vaccine candidate
Durban, South Africa – Aspen is pleased to announce that one of its wholly-owned South African subsidiaries, Pharmacare Limited (which trades as “Aspen Pharmacare”), has
Divestment of Aspen’s European Thrombosis Business to Mylan and withdrawal of cautionary
Johannesburg – Following the release of a cautionary announcement on 24 August 2020, Aspen is pleased to announce that, Aspen Global Incorporated (“AGI”), its wholly
Aspen responds to President Cyril Ramaphosa’s call to action on COVID-19
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced that the Group is actively focused on
Aspen divests of its Japanese operations for up to R6.5 billion
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty and branded pharmaceutical company, is pleased to announced that its wholly
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
